N. Rhodes

发表

Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples

M. Yin, S. Cremers, Sean N. Avedissian, 2018, Antimicrobial Agents and Chemotherapy.

Decision models to improve healthcare-associated C. difficile PCR test use in patients with community-acquired pneumonia

R. Wunderink, P. Yarnold, S. Sutton, 2020, medRxiv.

Mask mandates can limit COVID spread: Quantitative assessment of month-over-month effectiveness of governmental policies in reducing the number of new COVID-19 cases in 37 US States and the District of Columbia

M. J. Maloney, P. Yarnold, N. Rhodes, 2020, medRxiv.

Implementing a Continuous or Prolonged Infusion Beta-Lactam Program in the Hospital Setting

M. Scheetz, S. MacVane, J. Kuti, 2016 .

Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches

J. Le, J. Bradley, Sean N. Avedissian, 2021, Antimicrobial Agents and Chemotherapy.

Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study

S. Tong, Joshua S. Davis, Jiajun Liu, 2020, Open forum infectious diseases.

Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network

J. Bosso, D. Goff, M. Rybak, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19

N. Rhodes, W. Moore, S. Raybardhan, 2021, Clinical Pharmacokinetics.

Urinary biomarker and histopathological evaluation of vancomycin and piperacillin-tazobactam nephrotoxicity in comparison with vancomycin in a rat model and a confirmatory cellular model

A. Zuppa, E. d’Aloja, A. Chalkias, 2019, bioRxiv.

Pharmacokinetics of centhaquin citrate in a rat model

M. Scheetz, S. Sharma, A. Gulati, 2016, The Journal of pharmacy and pharmacology.

Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.

M. Neely, H. Donnelly, A. Donayre, 2022, The Journal of antimicrobial chemotherapy.

Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational In Vivo Rat Model

A. Gilchrist, A. Hauser, Jiajun Liu, 2020, Antimicrobial Agents and Chemotherapy.

Evaluation of Dose Fractionated Polymyxin B on Acute Kidney Injury: A Translational In Vivo Model

A. Gilchrist, A. Hauser, Jiajun Liu, 2019, bioRxiv.

A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime

M. Joshi, Sean N. Avedissian, M. Scheetz, 2019, mSphere.

Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients

M. Yin, Sean N. Avedissian, M. Scheetz, 2018, Antimicrobial Agents and Chemotherapy.

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.

David R. Jones, M. Scheetz, P. Kiel, 2017, International journal of antimicrobial agents.

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury

S. Briyal, M. Joshi, M. Scheetz, 2017, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation

Dawn L. Moore, David R. Jones, M. Scheetz, 2016, Pharmacotherapy.

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity.

M. Neely, D. Nicolau, M. Scheetz, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

M. Neely, D. Nicolau, Jiajun Liu, 2015, Antimicrobial Agents and Chemotherapy.

Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.

A. G. Ellis, N. Lawrentschuk, M. Neely, 2015, The Journal of antimicrobial chemotherapy.

Urinary Metabolomics from a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury

E. d’Aloja, A. Chalkias, T. Xanthos, 2021, bioRxiv.

A Review of the Clinical Pharmacokinetics of Polymyxin B

Andrew Lee, A. Hauser, Jiajun Liu, 2019, Antibiotics.

Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study

Brian M. Hoff, M. Postelnick, S. Sutton, 2019, Infection Control & Hospital Epidemiology.

Antibiotic choice for Group B Streptococcus prophylaxis in mothers with documented penicillin allergies and associated newborn outcomes

L. Mithal, N. Rhodes, M. Son, 2022, medRxiv.

Defining the Importance of Age-Related Changes in Drug Clearance to Optimizing Aminoglycoside Dosing Regimens for Adult Patients with Cystic Fibrosis

Brian M. Hoff, Manu Jain, Joanne F. Cullina, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

Opportunities for antibiotic stewardship among carbapenem-treated patients within 18 North American hospitals.

J. Bosso, D. Goff, M. Rybak, 2020, International journal of antimicrobial agents.

Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19

L. Schulz, M. Postelnick, M. Badowski, 2020, medRxiv.

Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse

M. Scheetz, J. Esterly, N. Rhodes, 2015, Antimicrobial Agents and Chemotherapy.

Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago

C. Bethel, Kamaljit Singh, A. Charnot-Katsikas, 2018, Antimicrobial Agents and Chemotherapy.

Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.

M. Postelnick, Sonia N. Rao, S. Sutton, 2017, International journal of antimicrobial agents.

Piperacillin-Tazobactam Added to Vancomycin Increases Risk for AKI: Fact or Fiction?

Jiajun Liu, Sean N. Avedissian, M. Scheetz, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

C. Ghossein, M. Scheetz, N. Rhodes, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR)

M. Postelnick, S. Sutton, D. Aljefri, 2019, Antimicrobial Agents and Chemotherapy.

Exploring the Relationship between FEV1 Loss and Recovery and Aminoglycoside Pharmacokinetics in Adult Patients with Cystic Fibrosis: Implications for Clinical Dosing Strategies

Brian M. Hoff, Manu Jain, Joanne F. Cullina, 2020, Pharmacotherapy.

Discrepancies Between Patient Self-Reported and Electronic Health Record Documentation of Medication Allergies and Adverse Reactions in the Acute Care Setting: Room for Improvement

N. Rhodes, A. Kabakov, R. Wenzel, 2019, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.

M. Joshi, Jiajun Liu, M. Scheetz, 2017, International journal of antimicrobial agents.

β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill.

F. Taccone, J. Roberts, J. Ungerer, 2019, The Journal of antimicrobial chemotherapy.

Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a Academic Hospital

A. Hauser, E. Ozer, M. Scheetz, 2021 .

β-lactam Dosing Strategies: Think before You Push.

J. Roberts, Jiajun Liu, M. Scheetz, 2020, International journal of antimicrobial agents.

Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.

M. Scheetz, N. Rhodes, J. O’Donnell, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Assessment of Mortality Stratified by Meropenem MIC in Patients with Enterobacteriaceae Bacteremia: A Patient-level Analysis of Published Data.

Elizabeth B. Hirsch, J. Esterly, T. Patel, 2019, International journal of antimicrobial agents.

Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.

Jiajun Liu, M. Scheetz, N. Rhodes, 2015, Diagnostic microbiology and infectious disease.

Cefazolin vs. anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections in acutely ill adult patients: Results of a systematic review and meta-analysis.

M. Scheetz, N. Rhodes, Sheila K. Wang, 2019, International journal of antimicrobial agents.

Resolution of acyclovir‐associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature

W A Watson, W. Watson, M. Angarone, 2017, Journal of clinical pharmacy and therapeutics.

Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections

Sonia N. Rao, M. Scheetz, J. Segreti, 2015, Antimicrobial Agents and Chemotherapy.

Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention

K. Downes, Jiajun Liu, Sean N. Avedissian, 2020, Pharmacotherapy.

Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury

A. Zuppa, K. Downes, Sean N. Avedissian, 2019, Antimicrobial Agents and Chemotherapy.

Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats

Anil Gulati, M. Neely, Thomas P. Lodise, 2016, Antimicrobial Agents and Chemotherapy.

Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.

A. Zuppa, E. d’Aloja, A. Chalkias, 2020, The Journal of antimicrobial chemotherapy.

A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and Underutilization

Richard G Wunderink, Cristina Miglis, Nathaniel J Rhodes, 2017, Infection Control & Hospital Epidemiology.

Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19

N. Rhodes, W. Moore, S. Raybardhan, 2021, Clinical Pharmacokinetics.

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis*

J. Roberts, J. Dulhunty, Jiajun Liu, 2017, Critical care medicine.

Unacceptably High Error Rates in Vitek 2 Testing of Cefepime Susceptibility in Extended-Spectrum-β-Lactamase-Producing Escherichia coli

Jiajun Liu, M. Scheetz, M. Malczynski, 2014, Antimicrobial Agents and Chemotherapy.

Role of Therapeutic Drug Monitoring in the Treatment of Persistent Mycobacterium abscessus Central Nervous System Infection: A Case Report and Review of the Literature

Brian M. Hoff, P. Santoiemma, N. Rhodes, 2022, Open forum infectious diseases.

DABIGATRAN ETEXILATE: THE FIRST FDA-APPROVED ORALLY AVAILABLE DIRECT THROMBIN INHIBITOR

N. Rhodes, 2011 .

Empiric Carbapenems for Nosocomial Pneumonia: Is Hindsight Clearer in 2020?

R. Wunderink, N. Rhodes, 2021, Chest.

Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis.

M. Postelnick, D. Aljefri, Sean N. Avedissian, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes.

M. Scheetz, J. Kuti, N. Rhodes, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model

P. Yarnold, E. Barreto, M. Scheetz, 2023, bioRxiv.

Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital

Arghavan Alisoltani, A. Hauser, E. Ozer, 2021, medRxiv.

Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia

R. Wunderink, A. Hauser, N. Rhodes, 2018, Current Infectious Disease Reports.

Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption.

M. Scheetz, T. Zembower, M. Malczynski, 2017, Diagnostic microbiology and infectious disease.

Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework

M. Postelnick, S. Sutton, M. Scheetz, 2016, Antimicrobial Agents and Chemotherapy.

Long-term Persistence of an Extensively Drug Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center.

A. Oliver, J. Mekalanos, Jonathan P. Allen, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia

R. Wunderink, P. Yarnold, S. Sutton, 2021, Antimicrobial agents and chemotherapy.

Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships

S. Tong, M. Neely, T. Holland, 2021, Antimicrobial agents and chemotherapy.

Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships

S. Tong, M. Neely, T. Holland, 2021, bioRxiv.

Effect of Omadacycline Alone and in Combination with Meropenem against Carbapenem-Resistant Acinetobacter baumannii isolates.

E. Ozer, N. Rhodes, J. O’Donnell, 2022, Journal of Global Antimicrobial Resistance.

Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia

P. Yarnold, A. Pawlowski, S. Sutton, 2022, Antimicrobial agents and chemotherapy.

Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes

L. Mithal, N. Rhodes, M. Son, 2023, BMC Pregnancy and Childbirth.

Impact of vancomycin treatment duration and dose on kidney injury.

M. Postelnick, M. Scheetz, J. Esterly, 2014, International journal of antimicrobial agents.

Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients

M. Yin, S. Cremers, Sean N. Avedissian, 2018, Pharmacotherapy.

Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.

M. Scheetz, N. Rhodes, J. O’Donnell, 2018, International journal of antimicrobial agents.

Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes

M. Postelnick, S. Sutton, Sean N. Avedissian, 2018, The Journal of antimicrobial chemotherapy.

Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics

S. Davis, M. Scheetz, Jamie L. Wagner, 2016, Infection Control & Hospital Epidemiology.

Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing

M. Neely, Jiajun Liu, C. Peloquin, 2020, Antimicrobial Agents and Chemotherapy.

Clinical pharmacokinetics of ceftolozane and tazobactam in an obese patient receiving continuous venovenous hemodiafiltration: A patient case and literature review.

Christina A. Sutherland, D. Nicolau, Ahmed Mahmoud, 2020, Journal of global antimicrobial resistance.

Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections.

M. Scheetz, J. Esterly, N. Rhodes, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study: Impact of stewardship on BSI outcomes.

Brian M. Hoff, M. Postelnick, S. Sutton, 2021, International journal of antimicrobial agents.

Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window.

D. Nicolau, M. Scheetz, Cristina M Miglis, 2017, International journal of antimicrobial agents.

Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.

Jiajun Liu, C. Peloquin, M. Scheetz, 2023, The Journal of antimicrobial chemotherapy.

Correlation between hospital‐level antibiotic consumption and incident health care facility‐onset Clostridium difficile infection

S. Sutton, M. Scheetz, Cristina M Miglis, 2017, American journal of infection control.

Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU.

J. Le, J. Bradley, Sean N. Avedissian, 2019, The Journal of antimicrobial chemotherapy.

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime

J. Roberts, J. Lipman, Jiajun Liu, 2019, Clinical Pharmacokinetics.

The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients

Sean N. Avedissian, P. Beringer, A. Rao, 2019, Pharmacotherapy.

Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics.

M. Neely, J. Le, M. Rybak, 2021, The Journal of antimicrobial chemotherapy.

High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin

M. Joshi, M. Scheetz, N. Rhodes, 2017, Clinical and translational science.

Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity

N. Iovine, Jiajun Liu, C. Peloquin, 2022, Pharmacotherapy.

Use of Therapeutic Drug Monitoring to Characterize Cefepime-Induced Neurotoxicity

N. Iovine, Jiajun Liu, C. Peloquin, 2020 .

Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

C. Ghossein, M. Scheetz, N. Rhodes, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

M. Postelnick, E. Spivak, N. Rhodes, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Implementing Infection Prevention for Leech Therapy

M. Postelnick, M. Bolon, T. Zembower, 2019, American Journal of Infection Control.

Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis.

M. Postelnick, D. Aljefri, Sean N. Avedissian, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.